Skip to main content
. 2024 Feb 9;14:3335. doi: 10.1038/s41598-024-53976-3

Figure 5.

Figure 5

Inhibition of Nrf2 aggravates LPS-induced HUVECs ferroptosis and inflammation. (A) Western blot was used to verify the inhibition effect of Nrf2 in endothelial cells by ML385(5 μM) treatment at different times (0, 6, 12, and 24 h); ***P < 0.001 versus 0 h group. (B) CCK8 was used to detect cell viability after LPS treatment for 24 h; **P < 0.01, ***P < 0.001. (C) The DCFH-DA probes were performed for ROS levels (scale bar, 200 μm) after LPS treatment for 3 h. (D) The iron ion, GSH, and MDA levels were measured after LPS treatment for 6 h; *P < 0.05, **P < 0.01, ***P < 0.001. (E) The ferroptosis-related protein expression levels were measured by western blot after LPS treatment for 6 h; *P < 0.05 versus Control group, #P < 0.05 versus LPS group. (F) The LPS (6 h)-induced inflammation-related proteins after ML385(5 μM) treatment were measured by western blot ; *P < 0.05 versus Control group, #P < 0.05 versus LPS group, ¥P < 0.05 versus LPS + ML385 group.